Somalogic Operating Co., Inc.
Boulder, CO Doing business as CM Life Sciences II Inc. Part of Standard Biotools Inc.
- UEI
- CTK7E4CB43M7
- CAGE
- 3Q4R1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Standard Biotools Inc.
Parent
Q7U7QSDD32W4
- Somalogic Operating Co., Inc. CTK7E4CB43M7
-
Standard Biotools Inc.
Parent
Q7U7QSDD32W4
- SAM.gov registration date
- Physical address
- 2945 Wilderness Pl, Boulder, CO 80301, USA
- Website
- somalogic.com
- Founded
- 2000
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398 | Food and Drug Administration | $149,500 | |
| Protein measurement services for research project. | Veterans Integrated Service Network 5 | $45,000 | |
| Somascan assay kits | Office of Logisitics and Acquisition Operations | $522,030 | |
| Biological material - somascan 11K assay V5.0 human plasma, no slide kit | National Institute on Aging | $16,106 | |
| Genomic services | Food and Drug Administration | $273,650 |
About Somalogic Operating Co., Inc.
Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., manufactures and delivers proteomics assay kits and protein measurement services to federal research agencies as a prime contractor, with 99% of its recent awards in a prime capacity and no reliance on set-aside designations. The company is a for-profit manufacturer of goods headquartered in Boulder, Colorado, and operates as a subsidiary of Standard Biotools Inc. (formerly Fluidigm). Somalogic's federal footprint centers on its proprietary SomaScan platform — an aptamer-based assay technology that simultaneously measures up to 11,000 proteins in small-volume biosamples (plasma, serum, cerebrospinal fluid, urine, and tissue variants) — sold as kits, discovery services, and laboratory testing across civilian research and regulatory science programs.
Customer concentration is highly skewed toward the Department of Health and Human Services and its National Institutes of Health components. The top five customer agencies account for 90% of combined potential value: the National Institute of Allergy and Infectious Diseases leads by award count (26 awards, $8.5 million combined potential value), followed by the FDA (14 awards, $7.9 million), the National Institute on Aging (15 awards, $4.4 million), the National Institute on Drug Abuse (9 awards, $3.5 million), and the National Heart, Lung and Blood Institute (24 awards, $3.4 million). NIAID dominates both volume and dollars across the recent footprint. Somalogic holds a five-year FDA Indefinite Delivery/Indefinite Quantity contract (awarded September 19, 2025, valued at $2,002,500.00, completing September 28, 2030) for proteomic services supporting regulatory science and product evaluation; it also places task orders under the FDA's existing IDIQ 75F40120D00018 (five task orders, $797 thousand combined potential value) and HHSN271201500010I (four task orders, $611 thousand). Representative prime awards include a $2,053,318 purchase order from NIAID (April 18, 2025) for 59 SomaScan assay kits to support the Center for Human Immunology's systems immunology research, a $2,099,999.92 purchase order from the National Institute on Aging (August 15, 2023) for 53 SomaScan 7K kits to the National Institute on Drug Abuse for Alzheimer's disease proteomics research, a $1,083,600 purchase order from the National Institute on Drug Abuse (September 1, 2021) for discovery-based proteomics analysis of approximately 1,800 plasma samples from the Baltimore Longitudinal Study of Aging, and a $970,037.50 sole-source contract from the Defense Health Agency (May 2, 2023) for assay services validating psychological health biomarkers in service members.
Award activity peaked in 2023 (19 awards) and has declined since — 13 awards in 2024, 7 in 2025, and 1 in 2026 — reflecting the mature, variable nature of the proteomics services market. Combined potential value across all 121 awards sits at $30.8 million, with $24.3 million obligated (79% realization rate). Four awards (combined potential value $2.1 million) complete within the next twenty-four months, exposing modest recompete risk. Somalogic's capability framing clusters around biological product manufacturing (40 awards), biotechnology research and development (28 awards), and testing laboratory services (16 awards), with top PSC codes spanning reference laboratory testing (34 awards), drugs and biologicals (26 awards), and laboratory equipment and supplies (18 awards). The company subcontracts minimally — one recorded federal grant sub-award through the University of Texas Southwestern Medical Center (November 12, 2024) for aptamer-based proteomic assay services and analysis interpretation. Federal agencies consistently award Somalogic on sole-source, non-competitive grounds, citing the SomaScan platform's unique capability to measure protein concentration ranges, sample volume efficiency, reproducibility, and throughput that alternative proteomics technologies cannot match.
Quick answers
What is Somalogic Operating Co., Inc.'s UEI?
Somalogic Operating Co., Inc.'s Unique Entity ID (UEI) in SAM.gov is CTK7E4CB43M7.
What is Somalogic Operating Co., Inc.'s CAGE code?
Somalogic Operating Co., Inc.'s CAGE code is 3Q4R1.
What is Somalogic Operating Co., Inc.'s primary NAICS code?
Somalogic Operating Co., Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Somalogic Operating Co., Inc. located?
Somalogic Operating Co., Inc.'s physical address in SAM.gov is 2945 Wilderness Pl, Boulder, CO 80301, USA.
Is Somalogic Operating Co., Inc. registered in SAM.gov?
Yes. Somalogic Operating Co., Inc.'s SAM.gov registration is active through April 9, 2027.
Who is Somalogic Operating Co., Inc.'s parent company?
Somalogic Operating Co., Inc. is part of Standard Biotools Inc.
What is Somalogic Operating Co., Inc.'s most recent federal award?
Somalogic Operating Co., Inc.'s most recent federal contract award is EO 14398 (75F40126F19002), from Food and Drug Administration, on August 14, 2026.
On GovTribe
See Somalogic Operating Co., Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors